Business
BioMarin Announces Closing of Private Offering of Senior Notes
BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) ("BioMarin") announced today that it closed its previously announced offering of $850 million of 5.500% senior unsecured notes due 2034 (the "Notes"). The issue price of the Notes is 100.000%.
About this update from Biomarin Pharmaceutical Inc.
[{"type":"text","content":"SAN RAFAEL, Calif., Feb. 12, 2026 /PRNewswire/ -- BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) ("BioMarin") announced today that it closed its previously announced offering of $850 million of 5.500% senior unsecured notes due 2034 (the "Notes"). The issue price of the Notes is 100.000%.","length":306,"tagName":"p"},{"type":"image","alt":"BioMarin Pharmaceutical logo (PRNewsfoto/BioMarin Pharmaceutical Inc.)","displaySize":"","headline":null,"caption":"BioMarin Pharmaceutical logo (PRNewsfoto/BioMarin Pharmaceutical Inc.)","className":"","disableSlideshowImg":false,"size":{"original":{"width":400,"height":59,"url":"https://media.zenfs.com/en/prnewswire.com/db94610f2d68c7fd655942d2889db5d2"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/KxRqzB62ez2RdMQaPUuMVg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTcwNTtoPTEwNDtjZj13ZWJw/https://media.zenfs.com/en/prnewswire.com/db94610f2d68c7fd655942d2889db5d2","width":400,"height":59}},"href":"https://mma.prnewswire.com/media/534018/BioMarin_Pharmaceutical_Inc_Logo.html","hrefExternal":true,"rel":"nofollow"},{"type":"text","content":"BioMarin intends to use the net proceeds from the offering of the Notes, together with borrowings under a new $2 billion senior secured term loan "B" facility (the "Term Loan B Facility") and $800 million senior secured term loan "A" facility (the "Term Loan A Facility" and, together with the Term Loan B Facility, the "Term Facilities") and cash on hand, to fund the consideration payable in connection with the pending acquisition (the "Acquisition") of Amicus Therapeutics, Inc. ("Amicus") and related fees and expenses in connection with the Acquisition and borrowings under the Term Facilities and the offering of the Notes. In addition to the Term Facilities, BioMarin expects to enter into a $600 million senior secured revolving credit facility connection with the Acquisition (the "New Revolving Facility" and, together with the Term Facilities, the "New Senior Secured Credit Facilities"). BioMarin may borrow up to $150 million under the New Revolving Facility to pay such fees and expenses.","length":1103,"tagName":"p"},{"type":"text","content":"Gross proceeds from the offering of the Notes were deposited into an escrow account at the closing of the offerin...